Combining 3D Cell Culture Chemosensitivity Results and NGS Profiles to Maximize Outcomes in Glioblastoma
High Grade Glioma (HGG) Functional Precision Medicine—A Six Webinar Series
SESSION 4 of 6
-
Date Recorded:February 22, 2024
-
Recording Length:54:11
-
Topics:
For this fourth installment of a six-webinar series, join us to hear how Dr. Odia of the Miami Cancer Institute at Baptist Health South Florida is using 3D Cell culture chemosensitivity results and NGS profiles to maximize outcomes in glioblastoma.
HGG patients have an extremely poor prognosis. Limited diagnostic tools are available to accurately predict treatment responses, leading to challenges in selecting effective therapeutic options. This interactive discussion will feature real world clinical cases, presented by Dr. Odia of the Miami Cancer Institute at Baptist Health South Florida, where a new functional precision oncology assay was used to direct therapy. There will be time for attendees to participate in interactive Q&A.
This Functional Precision Medicine Webinar Series is powered by OncoLens. On a single, secure platform, OncoLens data science, informatics and advanced collaboration tools provide a first of a kind platform for targeted treatment planning and confident clinical decision making.
Watch Session Cases Individually
Case #1 — Recurrence after Chemoradiation
69 yo F p/w balance issues, left facial droop, and left leg weakness
Pathology: WHO grade 4 glioblastoma IDH-wildtype, MGMT unmethylated
Location: Right temporal lobe
Progression @ 1 year
Case #2 — Multifocal Glioblastoma
42 yo F p/w headache, generalized tingling, and facial numbness
Pathology: WHO grade 4 glioblastoma IDH-wildtype, MGMT unmethylated
Location: Lateral right frontal
Progression @ 6 months
Case #3 — BRAF-mutant Glioblastoma
67 yo F with showed seizures
Pathology: WHO grade 4 glioblastoma BRAF-V600E mutation
Location: Right temporoparietal
Progression @ 7 years after treatment holiday
Case #4 — Post-Radiation Changes
62 yo M p/w expressive aphasia
Pathology: c/w glioblastoma IDH-wildtype, MGMT methylated
Location: Left inferior temporal gyrus
FEATURED SPEAKER:
Yazmin Odia, MD, MS, FAANS
Chief of Neuro-Oncology
Miami Cancer Institute
Baptist Health South Florida
High Grade Glioma (HGG) Functional Precision Medicine Webinar Series
MODERATOR:
Scott Isacksen
National Sales Director
Kiyatec
Other Sessions
- Session 1 — Watch Dr. Litvack and Dr. Phillips discuss their HGG cases
- Session 2 — Watch Dr. Mrugala of the Mayo Clinic discuss his HGG cases
- Session 3 — Watch Dr. Rodriguez of the University of Arkansas discuss her HGG cases
- Session 4 — Watch Dr. Odia from Miami Cancer Institute at Baptist Health South Florida discuss her HGG cases
- Session 5 — Watch Dr. Ryan from Virginia Mason Medical Center discuss his HGG cases
- Session 6 — details to be announced